Effect of the myorelaxant clenbuterol on the oxytocin-induced release of prostaglandin F2 alpha in ovariectomized heifers.
Clenbuterol, as other sympathomimetic drugs, relaxes the myometrium, thus causing a short-term inhibition of labor and the delay of parturition. This study has examined the influence of clenbuterol on the release of prostaglandin F2 alpha (PGF2 alpha) induced by oxytocin alone or with estradiol-17 beta. Five bilaterally ovariectomized heifers, primed with progesterone for 14 days, were used in two experiments. In the first they received two i.v. injections of oxytocin 6h apart, with and without an i.v. injection of clenbuterol before the second oxytocin injection; the second experiment was similar to the first except that the animals were given estradiol-17 beta 30 min after the first oxytocin injection. Frequent blood samples were taken for the measurement of 13,14-dihydro-15-keto-PGF2 alpha by radioimmunoassay. The data show that clenbuterol does not influence PGF2 alpha release in response to oxytocin alone or with estradiol-17 beta, and it does not inhibit the basal release of PGF2 alpha. This suggests that clenbuterol does not act on the endometrium to alter the secretion of PGF2 alpha in the non-pregnant cow.
Lafrance
M
M
Centre de recherche en reproduction animale, Faculté de médecine vétérinaire, Université de Montréal, St-Hyacinthe, Québec, Canada.
Goff
A K
AK
Vaillancourt
D
D
Guay
P
P
D000818:Animals; D002417:Cattle; D002976:Clenbuterol / Q000494:pharmacology*; D015237:Dinoprost / Q000031:analogs & derivatives; D004717:Endometrium / Q000187:drug effects / Q000378:metabolism*; D004958:Estradiol / Q000494:pharmacology; D004983:Ethanolamines / Q000494:pharmacology*; D005260:Female; D007700:Kinetics; D010052:Ovariectomy; D010121:Oxytocin / Q000494:pharmacology*; D011460:Prostaglandins F / Q000378:metabolism*
D004983:Ethanolamines; D011460:Prostaglandins F; C008228:15-keto-13,14-dihydroprostaglandin F2alpha; D004958:Estradiol; D010121:Oxytocin; D015237:Dinoprost; D002976:Clenbuterol